Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1940-1947. doi: 10.1002/jcsm.12796. Epub 2021 Sep 20.
Malnutrition is associated with poor survival in pancreatic cancer patients. Nutritional scores show great heterogeneity diagnosing malnutrition. The aim of this study was to find the score best suitable to identify patients with malnutrition related to worse survival after surgery for pancreatic ductal adenocarcinoma (PDAC). This study represents a follow-up study to the prospective NURIMAS Pancreas trial that evaluated short term impact of nutritional score results after surgery.
Risk of malnutrition was evaluated preoperatively using 12 nutritional assessment scores. Patients were followed-up prospectively for at least 3 years. Patients at risk for malnutrition were compared with those not at risk according to each score using Kaplan-Meier survival statistics.
A total of 116 patients receiving a PDAC resection in curative intent were included. Malnutrition according to the Subjective Global Assessment score (SGA), the Short Nutritional Assessment Questionnaire (SNAQ), and the INSYST2 score was associated with worse overall survival (SGA: at-risk: 392 days; not at-risk: 942 days; P = 0.001; SNAQ: at-risk: 508 days; not at-risk: 971 days; P = 0.027; INSYST2: at-risk: 538 days; not at risk: 1068; P = 0.049). In the multivariate analysis, SGA (hazard ratio of death 2.16, 95% confidence interval 1.34-3.47, P = 0.002) was associated with worse overall survival.
Malnutrition as defined by the Subjective Global Assessment is independently associated with worse survival in resected PDAC patients. The SGA should be used to stratify PDAC patients in clinical studies. Severely malnourished patients according to the SGA profit from intensified nutritional therapy should be evaluated in a randomized controlled trial.
营养不良与胰腺癌患者的生存不良相关。营养评分在诊断营养不良方面存在很大的异质性。本研究旨在找到最适合识别接受胰导管腺癌(PDAC)手术后与生存不良相关的营养不良患者的评分。本研究是对前瞻性 NURIMAS Pancreas 试验的随访研究,该试验评估了手术后营养评分结果对短期的影响。
使用 12 种营养评估评分来评估术前的营养不良风险。对至少 3 年的患者进行前瞻性随访。根据每个评分,使用 Kaplan-Meier 生存统计数据,比较有风险的营养不良患者和无风险的患者。
共纳入 116 例接受根治性 PDAC 切除术的患者。根据主观整体评估(SGA)、简短营养评估问卷(SNAQ)和 INSYST2 评分,营养不良与总体生存不良相关(SGA:有风险:392 天;无风险:942 天;P=0.001;SNAQ:有风险:508 天;无风险:971 天;P=0.027;INSYST2:有风险:538 天;无风险:1068 天;P=0.049)。在多变量分析中,SGA(死亡风险比为 2.16,95%置信区间为 1.34-3.47,P=0.002)与总体生存不良相关。
SGA 定义的营养不良与接受切除术的 PDAC 患者的生存不良独立相关。SGA 应用于临床研究中 PDAC 患者的分层。根据 SGA 严重营养不良的患者应在随机对照试验中接受强化营养治疗的评估。